stocktools
Dilution profile // every instrument, one screen, from SEC filings

Immunocore Holdings plc (IMCR)

CIK 1671927 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGHS-3ASR on file 2024-03-21
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
LOW+3% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
LOW~986 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-12-312026-07-31

Latest: 51.5M shares as of Jul 31, 2026 (10-Q).

Cash runway

Self-funding

generates cash

Full breakdown: cash runway tool · source filing →

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

NotePrincipalCarryingConv. priceRateIf converted
Convertible Senior Notes$402.5M—not tagged3.06%—

Notes exactly as the company dimensioned them in its 10-Q filed Aug 6, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.

Registrations and offerings

S-3ASRMar 21, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 0 executed · 0 registered.

UPDATEMar 17, 2025Resale prospectus — existing holders registering to sell424B7 →
UPDATEApr 5, 2024Resale prospectus — existing holders registering to sell424B7 →
REGISTEREDMar 21, 2024Automatic shelf registration — effective immediately (large filers)S-3ASR →
EXECUTEDFeb 2, 2024Unregistered share sale disclosed (8-K item 3.02)8-K →
UPDATESep 30, 2022Resale prospectus — existing holders registering to sell424B7 →
EXECUTEDSep 9, 2022Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
UPDATEMay 5, 2022Resale prospectus — existing holders registering to sell424B7 →
REGISTEREDApr 4, 2022Automatic shelf registration — effective immediately (large filers)F-3ASR →
EXECUTEDFeb 8, 2021Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
REGISTEREDFeb 4, 2021F-1MEF registration — capacity to sell shares, not a sale yetF-1MEF →
EFFECTIVEFeb 4, 2021SEC declared a registration effective — selling can beginEFFECT →
EFFECTIVEFeb 4, 2021SEC declared a registration effective — selling can beginEFFECT →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full IMCR workspace